Can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin?

Research output: Contribution to journalArticle

Original languageEnglish (US)
Article number1117
JournalFrontiers in Microbiology
Volume6
Issue numberOCT
DOIs
StatePublished - 2015

Fingerprint

Rifampin
Mycobacterium tuberculosis
Tuberculosis
Animal Models
Clinical Trials

Keywords

  • Animal models
  • Clinical trial
  • Mycobacterium tuberculosis
  • Persistence
  • Reactivation
  • Rifampicin
  • Treatment improvement

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Cite this

@article{099de7738cf64523a54e00700bfe8be3,
title = "Can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin?",
keywords = "Animal models, Clinical trial, Mycobacterium tuberculosis, Persistence, Reactivation, Rifampicin, Treatment improvement",
author = "Noton Dutta and Petros Karakousis",
year = "2015",
doi = "10.3389/fmicb.2015.01117",
language = "English (US)",
volume = "6",
journal = "Frontiers in Microbiology",
issn = "1664-302X",
publisher = "Frontiers Media S. A.",
number = "OCT",

}

TY - JOUR

T1 - Can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin?

AU - Dutta, Noton

AU - Karakousis, Petros

PY - 2015

Y1 - 2015

KW - Animal models

KW - Clinical trial

KW - Mycobacterium tuberculosis

KW - Persistence

KW - Reactivation

KW - Rifampicin

KW - Treatment improvement

UR - http://www.scopus.com/inward/record.url?scp=84946846008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946846008&partnerID=8YFLogxK

U2 - 10.3389/fmicb.2015.01117

DO - 10.3389/fmicb.2015.01117

M3 - Article

C2 - 26528265

AN - SCOPUS:84946846008

VL - 6

JO - Frontiers in Microbiology

JF - Frontiers in Microbiology

SN - 1664-302X

IS - OCT

M1 - 1117

ER -